CLOROX COMPANY (CLX)

US1890541097 - Common Stock

167.64  +1.89 (+1.14%)

After market: 167.19 -0.45 (-0.27%)

Fundamental Rating

4

Overall CLX gets a fundamental rating of 4 out of 10. We evaluated CLX against 12 industry peers in the Household Products industry. CLX has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, CLX is valued expensive at the moment.



6

1. Profitability

1.1 Basic Checks

CLX had positive earnings in the past year.
CLX had a positive operating cash flow in the past year.
Each year in the past 5 years CLX has been profitable.
Each year in the past 5 years CLX had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 6.49%, CLX is in line with its industry, outperforming 50.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 595.00%, CLX belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 21.32%, CLX is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CLX is in line with the industry average of 15.29%.
The 3 year average ROIC (13.49%) for CLX is below the current ROIC(21.32%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.49%
ROE 595%
ROIC 21.32%
ROA(3y)4.96%
ROA(5y)8.24%
ROE(3y)78.73%
ROE(5y)102.47%
ROIC(3y)13.49%
ROIC(5y)15.84%

1.3 Margins

CLX has a Profit Margin (4.78%) which is in line with its industry peers.
CLX's Profit Margin has declined in the last couple of years.
CLX has a Operating Margin (15.88%) which is in line with its industry peers.
CLX's Operating Margin has declined in the last couple of years.
The Gross Margin of CLX (44.56%) is better than 66.67% of its industry peers.
In the last couple of years the Gross Margin of CLX has remained more or less at the same level.
Industry RankSector Rank
OM 15.88%
PM (TTM) 4.78%
GM 44.56%
OM growth 3Y-7.85%
OM growth 5Y-6.18%
PM growth 3Y-25.82%
PM growth 5Y-21.44%
GM growth 3Y-0.28%
GM growth 5Y-0.32%

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLX is creating value.
Compared to 1 year ago, CLX has more shares outstanding
Compared to 5 years ago, CLX has less shares outstanding
CLX has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 4.37 indicates that CLX is not in any danger for bankruptcy at the moment.
CLX's Altman-Z score of 4.37 is in line compared to the rest of the industry. CLX outperforms 58.33% of its industry peers.
CLX has a debt to FCF ratio of 3.72. This is a good value and a sign of high solvency as CLX would need 3.72 years to pay back of all of its debts.
CLX has a Debt to FCF ratio (3.72) which is in line with its industry peers.
CLX has a Debt/Equity ratio of 41.43. This is a high value indicating a heavy dependency on external financing.
CLX has a Debt to Equity ratio of 41.43. This is amonst the worse of the industry: CLX underperforms 91.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 41.43
Debt/FCF 3.72
Altman-Z 4.37
ROIC/WACC2.54
WACC8.39%

2.3 Liquidity

CLX has a Current Ratio of 1.00. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
CLX's Current ratio of 1.00 is on the low side compared to the rest of the industry. CLX is outperformed by 75.00% of its industry peers.
CLX has a Quick Ratio of 1.00. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
CLX has a Quick ratio of 0.62. This is in the lower half of the industry: CLX underperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.62

5

3. Growth

3.1 Past

CLX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.37%, which is quite impressive.
The Earnings Per Share has been decreasing by -0.51% on average over the past years.
Looking at the last year, CLX shows a small growth in Revenue. The Revenue has grown by 6.17% in the last year.
CLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.68% yearly.
EPS 1Y (TTM)62.37%
EPS 3Y-7.55%
EPS 5Y-0.51%
EPS Q2Q%279.59%
Revenue 1Y (TTM)6.17%
Revenue growth 3Y-1.14%
Revenue growth 5Y2.68%
Sales Q2Q%27.13%

3.2 Future

The Earnings Per Share is expected to grow by 7.27% on average over the next years.
The Revenue is expected to grow by 3.65% on average over the next years.
EPS Next Y11.94%
EPS Next 2Y9.12%
EPS Next 3Y7.83%
EPS Next 5Y7.27%
Revenue Next Year-1.32%
Revenue Next 2Y0.54%
Revenue Next 3Y1.33%
Revenue Next 5Y3.65%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.20, CLX is valued on the expensive side.
CLX's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.53, CLX is valued a bit cheaper.
With a Price/Forward Earnings ratio of 22.78, CLX is valued on the expensive side.
CLX's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.40. CLX is around the same levels.
Industry RankSector Rank
PE 22.2
Fwd PE 22.78

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLX is on the same level as its industry peers.
CLX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CLX is more expensive than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.02
EV/EBITDA 16.23

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLX does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CLX may justify a higher PE ratio.
PEG (NY)1.86
PEG (5Y)N/A
EPS Next 2Y9.12%
EPS Next 3Y7.83%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.94%, CLX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.42, CLX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.22, CLX pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.94%

5.2 History

The dividend of CLX has a limited annual growth rate of 4.43%.
CLX has paid a dividend for at least 10 years, which is a reliable track record.
CLX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)4.43%
Div Incr Years33
Div Non Decr Years33

5.3 Sustainability

167.23% of the earnings are spent on dividend by CLX. This is not a sustainable payout ratio.
The dividend of CLX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP167.23%
EPS Next 2Y9.12%
EPS Next 3Y7.83%

CLOROX COMPANY

NYSE:CLX (11/15/2024, 8:04:00 PM)

After market: 167.19 -0.45 (-0.27%)

167.64

+1.89 (+1.14%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap20.75B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.94%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 22.2
Fwd PE 22.78
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.86
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.49%
ROE 595%
ROCE
ROIC
ROICexc
ROICexgc
OM 15.88%
PM (TTM) 4.78%
GM 44.56%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 41.43
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1
Quick Ratio 0.62
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)62.37%
EPS 3Y-7.55%
EPS 5Y
EPS Q2Q%
EPS Next Y11.94%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.17%
Revenue growth 3Y-1.14%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y